A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2700 participants.

Also called NCT03716011

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,700 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03716011
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03716011. Allocation not applicable; no masking; primary purpose treatment. Start 2018-12-20 (anticipated); primary completion 2021-12-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT
Intervention (Device)
EXCROSSAL
Lead sponsor
JW Medical Systems Ltd (class: industry)

Record details

Record id
cardio:ct-nct03716011
Content hash
50fd636a5fa96c1f4f88b708b7e297b55c0eb9dc18033cc4b8610780bcea3be7